TGFBR1 and neoplasm: Transfer of miR-142-3p into endothelial cells promotes angiogenesis though inhibition of transforming growth factor beta 1 receptor (TGFβR1), while transfer to fibroblasts induces transformation to a CAF phenotype: both changes are associated with tumor progression.